Recently, there is a need of alternatives to antibiotics due to increasing antibiotic-resistant microorganism. Promising classes of bioactive polymers are 6-deoxy-6-amino cellulose derivatives. The purpose of the study was the assessment of the biocompatibility of 6-deoxy-6-aminoethyleneamino cellulose (AEAC) with different degree of substitution (DS). HaCaT keratinocyte cell viability was analyzed by measuring the cellular ATP content. The antibacterial activity against Staphylococcus aureus and Klebsiella pneumoniae was examined by microplate laser nephelometry. Thus, the ratio of half-maximal lethal concentration (LC 50 ) and half-maximal inhibitory concentration (IC 50 ) was calculated and described as biocompatibility index. The study revealed that biocompatibility of AEAC depends on the DS. AEAC of low DS (0.3) showed the best biocompatibility.
Introduction
There are different ways to deal with bacterial infections. To prevent or to treat bacterial infections antiseptics, disinfectants, antimicrobial peptides, or antibiotics are the means of choice. However, the latter are intensely discussed because frequent use of antibiotics leads to an increase of antibiotic resistance in bacteria.
Thus, there is a need for alternatives. Antimicrobial polymers are considered to be valid options for commonly used products [1] [2] [3] [4] [5] . A choice could Journal of Biosciences and Medicines be the use of chemically modified cellulose such as 6-deoxy-6-amino cellulose derivatives. A typical example of this novel class of cellulose derivatives is 6-deoxy-6-aminoethyleneamino cellulose (AEAC) [3] [4] [6] . AEAC is described to be biocompatible [2] and hemocompatible [7] .
AEACs are synthesized by nucleophilic displacement reaction of p-toluenesulfonic acid ester of cellulose with ethylene diamine [4] [7] [8] introducing amino moieties into the cellulose backbone that are water-soluble and may be positively charged depending on the pH value of the system [4] . The number of functional groups generated in the cellulose derivative is described as degree of substitution (DS) [9] . It is proposed that the functionalization with amino groups leads to antimicrobial activity. Besides antimicrobial efficacy, cytocompatibility is most important for the use of biomaterials in medical applications. Biocompatibility has become the central request for the medical application of materials and devices [10] [11] [12] [13] . Müller and Kramer defined a biocompatibility index (BI) for antiseptics based on the damage of murine fibroblasts and the MIC values for S. aureus and E. coli [14] . Following their approach [14] , the BI was used to rate antibacterial activity of AEAC and effects on human cells. Here, the BI was defined as the ratio of the half-maximal lethal concentration (LC 50 ) and the half-maximal inhibitory concentration (IC 50 ). Accordingly, a BI greater than 1 will describe a substance exhibiting a high antimicrobial activity combined with a relatively low cytotoxicity (Figure 1(a) ), whereas a BI less than 1 will indicate an antimicrobial effective sample with a relatively high cytotoxicity ( Figure  1(b) ).
The aim of this study was the assessment of biocompatibility of AEAC with different DS. With regard to cytocompatibility, HaCaT keratinocytes have been used as a model system to determine cell viability by measuring cellular ATP content. S. aureus and K. pneumoniae were used as model organisms to investigate antibacterial activity of AEAC using microplate laser nephelometry (MLN). The ratio of half-maximal lethal concentration (LC 50 ) and half-maximal inhibitory (a) (b) Figure 1 . The biocompatibility index (BI) is composed of the ratio of half maximal lethal concentration (LC 50 ) to half maximal inhibitory concentration (IC 50 ). A BI greater than 1 indicates a substance with a high antimicrobial activity and good cell compatibility. In contrast a BI less than 1 indicates indeed a high antimicrobial activity but more than 50% of the human cells are death. The dotted line marks cell viability or antimicrobial activity at 50%. In addition, we determined the effect of DS on cytocompatibility and antimicrobial activity.
Materials and Methods

Synthesis of 6-Deoxy-6-Aminoethyleneamino Cellulose
Water-soluble 6-deoxy-6-aminoethyleneamino cellulose (AEAC, Figure 2 ) was synthesized by nucleophilic displacement reaction of cellulose tosylate as described elsewhere [2] [7] . AEAC with different degree of substitution (DS) of 0.3, 0.5, 0.7, and 0.9 were prepared. The initial AEAC concentration was 10 mg/mL.
Serial AEAC dilutions were prepared with respective cultivation medium.
Cultivation of HaCaT Keratinocytes
Human HaCaT keratinocytes (kindly provided by N. E. Fusenig, German Cancer
Research Center Heidelberg, Germany) were cultured at 37˚C in a humidified atmosphere containing 5% CO 2 in Dulbecco's modified Eagle's medium (Promocell, Germany) supplemented with 1% antibiotic-antimycotic solution (Promocell, Germany) and 10% fetal bovine serum (Promocell, Germany) as described elsewhere [15] .
Determination of Cell Viability
HaCaT keratinocytes were incubated with AEAC dilutions for 24 h and afterwards cell viability was determined using a luminometric adenosine triphos- 
Cultivation of Bacteria
Staphylococcus aureus ATCC 6538 and Klebsiella pneumoniae ATCC 4352 were purchased from the DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen, Germany). Strain maintenance was performed on Columbia agar plates with 5% sheep blood (Biomeriéux, France). Bacterial suspensions were prepared in CASO medium (Oxoid, UK) according to Finger et al. [16] . 
Determination of Antibacterial Activity
Data Analysis and Statistics
Experiments and measurements were performed in duplicate each. All values are expressed as means ± SE. LC 50 and IC 50 values were calculated using a logistic fit function as described elsewhere [5] ( ) 
Results
Effects of AEAC on HaCaT Keratinocyte's Cell Viability
For assessment of AEAC with regard to its effect on viability of HaCaT keratinocytes, cellular ATP content was determined using a luminometric assay. Because ATP can only be determined in living cells, information on cell viability is obtained. Hence, HaCaT keratinocytes were incubated with dissolved AEAC of different DS over 24 h. In general, the AEAC of different DS were compatible to the HaCaT cells. However, LC 50 values showed a distinct tendency; cytocompatibility decreased with increasing DS. The AEAC with the low DS of 0.3 showed the highest cytocompatibility, whereas the AEAC with the highest DS (0.9) was less cytocompatible (Table 1 ). Figure 3 shows the dependence of HaCaT cell viability on concentration and DS of the AEAC samples. Already a concentration of 39 µg/mL showed a distinct difference on HaCaT cell viability. AEAC with DS higher 0.5 exhibited a reduction in cell viability of 33% (AEAC-DS0.7) or 38% (AEAC-DS0.9) compared to the control. In case of AEAC with DS of 0.7, a distinct decline in cell viability was observed at a concentration of 625 µg/mL. For the AEAC with low DS of 0.3, cell viability is influenced at concentration higher than 2500 µg/mL (data not shown).
Antibacterial Activity of AEAC
The growth of S. aureus and K. pneumoniae under the influence of AEAC was monitored by MLN (Figure 4) . It was found that the AEAC had bactericidal effects. It was shown that the antibacterial activity of AEAC depended on the DS. The IC 50 values for both bacteria (Table 1) illustrate an increase of antibacterial activity with increasing DS with the exception of AEAC with DS 0.3 and K. pneumoniae. The AEAC with the highest DS of 0.9 showed the strongest antibacterial effects, while the AEAC with the lowest DS of 0.3 was less effective against the bacteria. In general, AEAC were more effective against S. aureus compared to K. pneumoniae. For instance, 50% of S. aureus were inhibited with 20 µg/mL of AEAC with DS of 0.9, whereas threefold higher concentrations were needed to achieve the same effects on K. pneumoniae. In case of AEAC with DS of 0.7, the IC 50 for K. pneumoniae (132.79 µg/mL) is almost seven times higher than for S. aureus (17. 91 µg/mL). This trend was also observed for AEAC with DS of 0.5.
Biocompatibility of AEAC
The results of the cell viability assay and MLN were summarized as the ratio from LC 50 to IC 50 to determine the biocompatibility of AEAC. The value is referred to as biocompatibility index (BI). A BI greater than 1 indicates a substance with a high antimicrobial activity at the same concentration where more than 50% of the human cells are still viable in vitro, while, a BI less than 1 indicates a high antimicrobial activity, but a low cytocompatibility. This study demonstrated that the BI depends on the DS of AEAC. AEAC with the lowest DS of 0.3 was most compatible to HaCaT keratinocytes. The cytocompatibility decreases with increasing DS. This also applies to the determined BI (Table 1) . Thus, the cytocompatibility for AEAC with low DS is better than for AEAC with higher DS ( Figure 5 ). The highest BI from about 40 (S. aureus) and 50 (K. pneumoniae) could be calculated for AEAC with DS of 0.3 (Table 1 ). In addition, the BI determined with S. aureus was always higher than in connection with K. pneumoniae ( Figure 5 ). Nonetheless, the BI was greater than or nearly 1 for every AEAC tested. suitable model to determine effects of diverse substances on cytology in vitro [10] . The antibacterial activity was monitored with respect to the bacteria S. aureus und K. pneumoniae by MLN. As described previously, MLN is a sensitive and suitable method to determine the influence of substances on microbial hemolysis and markers for coagulation in human whole blood, human platelet rich plasma, human pooled plasma and erythrocytes suspensions [7] . It was described that AEAC showed concentration-and DS-dependent influence on hemocompatibility in vitro. Thus, AEAC with low DS had less influence on blood coagulation, a low hemolytic effect, and provided the highest hemocompatibility.
Discussion
As for the biocompatibility of AEAC, it is crucial to determine antibacterial activity besides the cytocompatibility. The antimicrobial activity of chitosan was frequently mentioned in literature [19] [28] [29] [30] and could give some hints for understanding the effects of AEAC on microorganism. Hosseinnejad and Jafari reviewed different factors and mechanisms, which play a role in antimicrobial activity of chitosan [31] . For instance, molecular weight, degree of acetylation, concentration, and pH value as well as microbial species are named as antimicrobial properties.
In the present study, the differences of antibacterial efficacy observed against S. aureus and K. pneumoniae of AEAC possibly depend on the morphological composition of bacterial cell walls. AEACs were most effective against the Gram-positive bacterium S. aureus. For K. pneumoniae, a Gram-negative bacterium, higher AEAC concentrations were needed to inhibit bacterial growth compared to S. aureus. Hence, S. aureus was more sensitive to AEAC than K. pneumoniae. Jou also described comparable observation when S. aureus and K. pneumoniae were incubated with the chitosan derivative chitosan-N-hydroxy-2,3-propyl-N-methyl-N,N-diallylammonium methyl sulfate [28] . On the con- It was found that AEAC with low DS (≤0.5) had less effect on cell viability of HaCaT keratinocytes than AEAC with higher DS (>0.5). Cell viability declined and antibacterial activity increased with increasing DS, except of AEAC-DS0.3 and K. pneumoniae. Whereat, S. aureus was more sensitive to the tested AEAC than K. pneumoniae.
AEAC with a maximum DS of 0.5 are most recommendable for medical applications because they showed the highest BI of all tested AEAC. Zieger et al.
came to the same conclusion and recommend AEAC with DS of 0.5 for applications that require inert materials [7] . AEAC with low DS exhibited the lowest anticoagulant and hemolytic potential of AEAC tested. In addition to AEAC solutions, also applications of corresponding nanoparticles are possible [4] [6] .
